Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $184.95 | 2 | 54.2% |
| Food and Beverage | $156.56 | 8 | 45.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $201.49 | 3 | $0 (2024) |
| Janssen Biotech, Inc. | $39.72 | 2 | $0 (2024) |
| Pharmacyclics LLC, An AbbVie Company | $34.69 | 2 | $0 (2023) |
| GENZYME CORPORATION | $29.41 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $19.03 | 1 | $0 (2024) |
| Daiichi Sankyo Inc. | $17.17 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $104.70 | 5 | Janssen Biotech, Inc. ($39.72) |
| 2023 | $34.01 | 2 | Daiichi Sankyo Inc. ($17.17) |
| 2022 | $202.80 | 3 | ABBVIE INC. ($184.95) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/17/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $29.41 | General |
| Category: Oncology | ||||||
| 06/27/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Oncology | ||||||
| 05/21/2024 | ABBVIE INC. | EPKINLY (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: ONCOLOGY | ||||||
| 02/06/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $19.03 | General |
| 01/25/2024 | Janssen Biotech, Inc. | DARZALEX (Drug) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: Oncology | ||||||
| 08/12/2023 | Pharmacyclics LLC, An AbbVie Company | EPKINLY (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: ONCOLOGY | ||||||
| 05/08/2023 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: ONCOLOGY | ||||||
| 10/13/2022 | ABBVIE INC. | VENCLEXTA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: ONCOLOGY | ||||||
| 10/13/2022 | ABBVIE INC. | VENCLEXTA (Drug) | Education | In-kind items and services | $85.95 | General |
| Category: ONCOLOGY | ||||||
| 07/08/2022 | Pharmacyclics LLC, an AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 52 | 72 | $18,940 | $3,791 |
| 2022 | 2 | 62 | 124 | $21,472 | $7,111 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 32 | 47 | $13,592 | $2,805 | 20.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 20 | 25 | $5,348 | $985.78 | 18.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 34 | 87 | $16,548 | $5,481 | 33.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 28 | 37 | $4,923 | $1,631 | 33.1% |
About Lisa Grolling, RN
Lisa Grolling, RN is a Community Health healthcare provider based in Hilton, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/28/2020. The National Provider Identifier (NPI) number assigned to this provider is 1427665082.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lisa Grolling, RN has received a total of $341.51 in payments from pharmaceutical and medical device companies, with $104.70 received in 2024. These payments were reported across 10 transactions from 6 companies. The most common payment nature is "Education" ($184.95).
As a Medicare-enrolled provider, Grolling has provided services to 114 Medicare beneficiaries, totaling 196 services with total Medicare billing of $10,902. Data is available for 2 years (2022–2023), covering 4 distinct procedure/service records.
Practice Information
- Specialty Community Health
- Other Specialties Family
- Location Hilton, NY
- Active Since 09/28/2020
- Last Updated 12/03/2021
- Taxonomy Code 163WC1500X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1427665082
Products in Payments
- VENCLEXTA (Drug) $184.95
- EPKINLY (Drug) $33.38
- SARCLISA (Biological) $29.41
- DARZALEX (Drug) $23.11
- IMBRUVICA (Drug) $17.85
- Enhertu (Drug) $17.17
- RYBREVANT (Drug) $16.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.